Coronavirus outbreak: Delhi overtakes Mumbai in total number of COVID-19 cases

While Delhi's tally has risen to over 70,000; the total number of COVID-19 positive cases in Mumbai stands at 69,625.

Moneycontrol News

June 24, 2020 / 21:45 IST

Representational picture

The number of coronavirus cases in the national capital have been rising rapidly, with the city reporting spikes in the daily caseload every day.

On June 24, Delhi recorded 3,788 new cases, pushing the total tally to over 70,000; essentially surpassing the total number of COVID-19 positive cases in Mumbai.

Of the 70,000 cases, 26,588 are active coronavirus cases and 41,437 are recovered cases. The death toll in the capital city has risen to 2,365, as per the latest figures from the health department.

As per the recent statement from Brihanmumbai Municipal Corporation (BMC), 1,144 new COVID-19 positive cases and 38 deaths reported in Mumbai on June 24. The total number of positive cases in the financial capital has risen to 69,625 including 37,010 recovered/discharged cases, 28,653 active cases and 3,962 deaths.

Delhi’s COVID-19 situation has been worsening over the past weeks, ever since the lockdown rules were relaxed. Delhi witnessed its biggest single-day jump in coronavirus cases on June 23, with 3,947 fresh infections being reported. It had already surpassed the total coronavirus cases reported in Tamil Nadu, which stands at nearly 65,000.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show